Mesenchymal stem cells (MSCs) represent a population of cells which have the ability to regulate reactivity of T and B lymphocytes by multiple mechanisms. The immunoregulatory activities of MSCs are strictly influenced by the cytokine environment. Here we show that two functionally distinct cytokines, interleukin-4 (IL-4) and interferon-γ (IFN-γ), significantly potentiate the ability of MSCs to inhibit IL-10 production by activated regulatory B cells (Bregs). However, MSCs in the presence of IL-4 or IFN-γ inhibit the IL-10 production by different mechanisms. Preincubation of MSCs with IFN-γ led to the suppression, but pretreatment with IL-4 of neither MSCs nor B cells resulted in the suppression of IL-10 production. The search for candidate regulatory molecules expressed in cytokine-treated MSCs revealed different patterns of the gene expression. Pretreatment of MSCs with IFN-γ, but not with IL-4, induced expression of indoleamine-2,3-dioxygenase, cyclooxygenase-2 and programmed cell death-ligand 1. To identify the molecule(s) responsible for the suppression of IL-10 production, we used specific inhibitors of the putative regulatory molecules. We found that indomethacine, an inhibitor of cyclooxygenase-2 (Cox-2) activity, completely abrogated the inhibition of IL-10 production in cultures containing MSCs and IFN-γ, but had no effect on the suppression in cell cultures containing MSCs and IL-4. The results show that MSCs can inhibit the response of B cells to one stimulus by different mechanisms in dependence on the cytokine environment and thus support the idea of the complexity of immunoregulatory action of MSCs.

Department of Cell Biology Faculty of Natural Science Charles University Vinicna 7 12843 Prague 4 Czech Republic

Department of Transplantation Immunology Institute of Experimental Medicine Czech Academy of Sciences Prague Videnska 1083 14220 Prague 4 Czech Republic

See more in PubMed

Exp Hematol. 2002 Jan;30(1):42-8 PubMed

Immunol Lett. 2007 Jun 15;110(2):91-100 PubMed

Blood. 2005 Feb 15;105(4):1815-22 PubMed

Immunol Cell Biol. 2013 Jan;91(1):19-26 PubMed

PLoS One. 2010 Apr 26;5(4):e10088 PubMed

Immunobiology. 2016 Feb;221(2):129-36 PubMed

Expert Opin Ther Targets. 2015 Feb;19(2):201-11 PubMed

Biorheology. 2004;41(3-4):469-76 PubMed

Lancet. 2004 May 1;363(9419):1439-41 PubMed

Blood. 2006 Jan 1;107(1):367-72 PubMed

Exp Hematol. 2009 May;37(5):604-15 PubMed

Cytokine. 2009 Apr;46(1):100-3 PubMed

Nature. 2012 Nov 8;491(7423):264-8 PubMed

Stem Cell Rev. 2012 Dec;8(4):1188-98 PubMed

Annu Rev Immunol. 2012;30:221-41 PubMed

Mol Cancer Ther. 2015 Apr;14(4):847-56 PubMed

Front Immunol. 2012 Jul 20;3:212 PubMed

Stem Cells Dev. 2014 Oct 15;23(20):2490-500 PubMed

J Exp Med. 1997 Nov 17;186(10):1749-56 PubMed

Cell Stem Cell. 2008 Feb 7;2(2):141-50 PubMed

Blood. 2005 Sep 1;106(5):1755-61 PubMed

Blood. 2012 Feb 23;119(8):1801-9 PubMed

Stem Cell Rev. 2012 Jun;8(2):375-92 PubMed

Exp Cell Res. 2005 Apr 15;305(1):33-41 PubMed

Blood. 2008 Feb 1;111(3):1327-33 PubMed

Immunol Lett. 2008 Jan 15;115(1):50-8 PubMed

Stem Cells Transl Med. 2015 Sep;4(9):1052-63 PubMed

Immunology. 2014 Apr;141(4):577-86 PubMed

Cell Stem Cell. 2012 May 4;10 (5):544-55 PubMed

J Intern Med. 2007 Nov;262(5):509-25 PubMed

Blood. 2002 May 15;99(10):3838-43 PubMed

Exp Mol Med. 2014 Jan 10;46:e70 PubMed

Curr Mol Med. 2012 Jun;12(5):519-27 PubMed

Perspectives and Limitations of Mesenchymal Stem Cell-Based Therapy for Corneal Injuries and Retinal Diseases

Metal Nanoparticles with Antimicrobial Properties: The Toxicity Response in Mouse Mesenchymal Stem Cells

Sertoli Cells Possess Immunomodulatory Properties and the Ability of Mitochondrial Transfer Similar to Mesenchymal Stromal Cells

Mesenchymal Stem Cell-Based Therapy for Retinal Degenerative Diseases: Experimental Models and Clinical Trials

Expression of Opioid Receptors in Cells of the Immune System

Cytokine interplay among the diseased retina, inflammatory cells and mesenchymal stem cells - a clue to stem cell-based therapy

Immunomodulatory Properties of Bone Marrow Mesenchymal Stem Cells from Patients with Amyotrophic Lateral Sclerosis and Healthy Donors

The Impact of Morphine on the Characteristics and Function Properties of Human Mesenchymal Stem Cells